Are patients with cancer receiving adequate thromboprophylaxis? Results from FRONTLINE

Cancer Treatment Reviews

Volumn 29, Issue SUPPL. 2, 2003, Pages 7-9

  Wolff, Robert A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer patients; Clinician survey; Low molecular weight heparin (LMWH); Oral anticoagulant thromboprophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CANCER PATIENT; CANCER SURGERY; CENTRAL VENOUS CATHETERIZATION; CLINICAL PRACTICE; CONTROLLED STUDY; GENERAL PRACTITIONER; GEOGRAPHY; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; NORTH AMERICA; PROPHYLAXIS; RISK ASSESSMENT; SURGICAL PATIENT; THROMBOEMBOLISM; UNITED STATES; VEIN THROMBOSIS;

EID: 0038206944     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(03)80002-6     Document Type: Article

References (0)